Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
11/2002
11/12/2002US6479735 Transgenic plants including a transgene consisting of a hybrid nucleic acid sequence, comprising at least one unedited mitochondrial gene fragment from higher plants and process for producing them
11/12/2002US6479734 DNA fragment responsive to low temperatures and a plant transformed with the DNA fragment
11/12/2002US6479733 Sterol metabolism enzymes
11/12/2002US6479732 cDNA of 4-coumarate: coenzyme a ligase and process for modifying lignin in plants
11/12/2002US6479730 DNA Ligase II orthologue uses thereof
11/12/2002US6479652 Oligonucleotide mediated nucleic acid recombination
11/12/2002US6479640 Antibody specific for a protein tyrosine phosphatase that localizes to focal adhesions
11/12/2002US6479630 Human purinergic P2U receptor
11/12/2002US6479629 Polypeptide; for use in the generation of disease resistant plants
11/12/2002US6479628 Methods and materials relating to IMPDH and GMP production
11/12/2002US6479508 Viral polymerase inhibitors
11/12/2002US6479291 Cytoplasmic inhibition of gene expression by viral RNA
11/12/2002US6479280 Recombinant phages capable of entering host cells via specific interaction with an artificial receptor
11/12/2002US6479274 DNA molecules encoding human HELA2 or testisin serine proteinases
11/12/2002US6479271 Genes encoding desulfurization enzymes
11/12/2002US6479270 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
11/12/2002US6479269 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/12/2002US6479268 7970, a novel ATPase-like molecule and uses thereof
11/12/2002US6479267 FY7 polymerase
11/12/2002US6479266 IKK-α proteins nucleic acids and methods
11/12/2002US6479265 Catalytic antibodies which hydrolyze primary amides and methods for eliciting and use of such antibodies
11/12/2002US6479264 Reversible inactivation enzymes
11/12/2002US6479263 Method for detection of micrometastatic prostate cancer
11/12/2002US6479260 Cold-inducible expression vector
11/12/2002US6479258 Non-stochastic generation of genetic vaccines
11/12/2002US6479245 Monoclonal antibody which is specific for activated coagulation factor VII, and its use
11/12/2002US6479055 Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission
11/12/2002CA2170515C Nucleotide sequences for novel protein tyrosine phosphatases
11/12/2002CA2101227C Chlorophyll and bacteriochlorophyll derivatives and pharmaceutical compositions containing them
11/12/2002CA2090493C Process for hydrolyzing hemicellulose by enzymes produced by trichoderma reesei
11/12/2002CA2088917C Therapeutic ribozyme compositions
11/12/2002CA2065245C Recombinant negative strand rna virus expression systems and vaccines
11/10/2002CA2382463A1 Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
11/07/2002WO2002089498A2 Selection method
11/07/2002WO2002088387A2 Amplification process
11/07/2002WO2002088370A2 Autogene nucleic acids encoding a secretable rna polymerase
11/07/2002WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme
11/07/2002WO2002088365A1 Process for producing coenzyme q¿10?
11/07/2002WO2002088364A1 ss1,3-GALACTOSE TRANSFERASE AND DNA ENCODING THE ENZYME
11/07/2002WO2002088363A2 Regulation of novel human prolyl 4-hydroxylases
11/07/2002WO2002088362A2 Regulation of human prostaglandin-f synthase 1-like protein
11/07/2002WO2002088350A1 Novel chalcone synthase-like genes and proteins
11/07/2002WO2002088345A2 Murine dnasex, medicament containing the same and non-human mammal comprising modified dnasex gene
11/07/2002WO2002088344A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/07/2002WO2002088343A2 RECOMBINANT EXPRESSION OF hHBV REVERSE TRANSCRIPTASE (RT)
11/07/2002WO2002088342A1 An enzyme preparation for improved baking quality and a process for preparing the same
11/07/2002WO2002088341A2 P450 proteins
11/07/2002WO2002088340A2 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
11/07/2002WO2002088303A2 Polynucleotide encoding a novel cysteine protease of the calpain superfamily, can-12, and variants thereof
11/07/2002WO2002088176A2 Genes and proteins for the biosynthesis of polyketides
11/07/2002WO2002088173A2 Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteins
11/07/2002WO2002088078A2 INHIBITORS OF GSK-3 AND CRYSTAL STRUCTURES OF GSK-3β PROTEIN AND PROTEIN COMPLEXES
11/07/2002WO2002087624A2 Uses of chemically-modified cholinesterases for detoxification of organophosphorus compounds
11/07/2002WO2002087531A1 Stabilised enzyme compositions
11/07/2002WO2002087510A2 Subcellular targeting of therapeutic proteins
11/07/2002WO2002072115A3 Vectors, compositions and methods for treating a vascular disorder
11/07/2002WO2002070721A3 Recombinant dimorphic fungal cell
11/07/2002WO2002052016A3 Regulation of human protein l-isoaspartate o-methyltransferase-like enzyme
11/07/2002WO2002050109A3 Nucleic acids coding for vacuolar invertases, vegetal cells and plants containing said nucleic acids and the use thereof
11/07/2002WO2002040684A3 Polynucleotide and polypeptide sequences of human purple acid phosphate
11/07/2002WO2002038745A3 Regulation of mitogen-activated protein kinase (mapk)
11/07/2002WO2002024927A3 Regulation of human adam-ts 1 precursor-like protein
11/07/2002WO2002024886A3 Regulation of human serine protease
11/07/2002WO2002024736A9 Polynucleotides and polypeptides associated with antibiotic biosynthesis and uses therefor
11/07/2002WO2002016586A3 Adenosine deaminase homolog
11/07/2002WO2002016561A3 Mfq-111, a novel human gtpase like protein
11/07/2002WO2002006458A3 Protease specific cleavable luciferases and methods of use thereof
11/07/2002WO2001098503A3 Regulation of human eosinophil serine protease 1-like enzyme
11/07/2002WO2001073056A3 Regulation of human oxoprolinase-like enzyme
11/07/2002WO2001049830A9 Improved lysosomal enzymes and lysosomal enzyme activators
11/07/2002WO2001045493A3 Transcription factor stress-related proteins and methods of use in plants
11/07/2002WO2001040449A9 Cloning of a gene encoding an amino acid racemase from trypanosoma cruzi, and uses thereof
11/07/2002WO2001029240A9 Regeneration
11/07/2002WO2001018218A9 Expression of proteins in genetically modified fungi
11/07/2002WO2001018045A9 Crystal structure of a deacetylase and inhibitors thereof
11/07/2002WO2001010454A9 Pharmaceutical composition comprising peg-asparaginase for the treatment of hiv infection
11/07/2002WO2000075293A3 Anti-fouling composition
11/07/2002US20020166145 Coffee mannanase
11/07/2002US20020166144 Nucleotide sequences coding polypeptide for us einthe generation of preferential coatings, resins, glues, plastics, surfactants and lubricants
11/07/2002US20020166143 Nucleotide sequences coding plypeptide for use in the generation of disease resistant plants
11/07/2002US20020166140 Mutated barnase gene and plant transformed by the same
11/07/2002US20020166138 FLP-mediated gene modification in mammalian cells, and compositions and cells useful therefor
11/07/2002US20020166137 LKB1 gene knockout animals
11/07/2002US20020166130 Expression of active human factor IX in mammary tissue of transgenic animals
11/07/2002US20020165386 C-junction-n-terminal kinase (JNK); microbiocides; treating neurodegenerative diseases
11/07/2002US20020165385 Plastidic phosphoglucomutase genes
11/07/2002US20020165377 ADAM polynucleotides, polypeptides, and antibodies
11/07/2002US20020165376 Novel human proteins (NHPs) share structural similarity with animal proteases, and encoded by a specific polynucleotide
11/07/2002US20020165345 Prostate cancer gene
11/07/2002US20020165344 Bacterial mutant for generating bacterial toxins for use in developing vaccine against infections
11/07/2002US20020165230 Gamma-ketoacid dipeptides as inhibitors of caspase-3
11/07/2002US20020165208 Administering testosterone inhibitor; polypeptide
11/07/2002US20020165194 Method for selective inactivation of viral replication
11/07/2002US20020165192 Grafting bone marrow; using inositol polyphosphatase; antigen for blocking gene expression
11/07/2002US20020165189 Oligoribonucleotides and ribonucleases for cleaving RNA
11/07/2002US20020165187 Isolated nucleic acids; therapy, diagnosis
11/07/2002US20020165166 Treating thrombosis by administering a CD154 inhibitor, such as a metalloproteinase inhibitor
11/07/2002US20020165158 Administering protein kinase C inhibitors
11/07/2002US20020165152 14089, a novel human trypsin serine protease and uses thereof
11/07/2002US20020165150 Amino acid sequence from certain regions of tissue growth factor-beta super family serine-threonine kinase receptors